Garland J. Scott Insider Trades & Stock Holdings

Director · Enliven Therapeutics, Inc. · Latest filing Oct 1, 2026

Garland J. Scott, Director at Enliven Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($606.72K), net -$606.72K. Latest filing: disposed of 13K shares of $ELVN on Oct 1, 2026 at $46.67.

Trades on file

1

Open-market bought

$0

Open-market sold

$606.72K

Net open-market

-$606.72K

Latest filing

Oct 1, 2026

All insider trades by Garland J. Scott

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$ELVN	Sell (Open-market sale)	13K	$46.67	$606.72K			-12.1%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Garland J. Scott traded

• $ELVN

Frequently asked questions

Has Garland J. Scott been buying or selling stock?

Garland J. Scott has 0 open-market purchases and 1 open-market sale on file, net -$606.72K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Garland J. Scott's latest insider trade?

disposed of 13K shares of $ELVN on Oct 1, 2026 at $46.67.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.